AV
Atlas Venture Fund XI, L.P.
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Insider active across 2 companies, notably Korro Bio, Inc.. In total, 17 reports have been recorded. History available since 22 June 2026. The latest transaction was disclosed on 26 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Atlas Venture Fund XI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
249 shares@ US$13.73Common StockSEC144:0001628280-26-059122
23,584 shares@ US$13.220.15% mcap8.1% of flowCommon StockSEC144:0001628280-26-058030
1,359,674 shares@ US$25.960.74% mcap58.5% of flowCommonSEC144:0001628280-26-057190
268,354 shares@ US$26.170.14% mcap28.1% of flowCommonSEC144:0001628280-26-056843
1,775 shares@ US$13.490.012% mcap0.7% of flowCommon StockSEC144:0001628280-26-055858
153,966 shares@ US$22.840.089% mcap37.6% of flowCommonSEC144:0001628280-26-047533
817 shares@ US$14.000.0056% mcap1.0% of flowCommon StockSEC144:0001628280-26-047352
253,039 shares@ US$23.070.15% mcap62.4% of flowCommonSEC144:0001628280-26-047357
85,955 shares@ US$13.650.55% mcap100.0% of flowCommon StockSEC144:0001628280-26-046978
102,969 shares@ US$20.940.044% mcap14.5% of flowCommonSEC144:0001628280-26-046094
162,954 shares@ US$20.610.069% mcap22.7% of flowCommonSEC144:0001628280-26-045819
12,699 shares@ US$20.330.0053% mcap1.5% of flowCommonSEC144:0001628280-26-045611
41,345 shares@ US$13.710.28% mcap16.5% of flowCommon StockSEC144:0001628280-26-045302
50,530 shares@ US$20.260.021% mcap5.8% of flowCommonSEC144:0001628280-26-045293
101,579 shares@ US$13.900.69% mcap41.1% of flowCommon StockSEC144:0001628280-26-044982
77,855 shares@ US$20.870.033% mcap9.1% of flowCommonSEC144:0001628280-26-044986
21,339 shares@ US$12.990.14% mcap8.0% of flowCommon StockSEC144:0001628280-26-044738
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. is a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. The declarant has 12 filings in total, and across the 12 recent filings available between 2026-06-22 and 2026-07-07, they show only sales for EUR 18590470, with the stated transaction nature being a notice of proposed sale (Form 144).